{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:55:15Z","timestamp":1791179715443,"version":"4.1.0"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"18","license":[{"start":{"date-parts":[[2004,9,15]],"date-time":"2004-09-15T00:00:00Z","timestamp":1095206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2004,9,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A chimeric yellow fever-dengue 1 (ChimeriVax-DEN1) virus was produced by the transfection of Vero cells with chimeric in vitro RNA transcripts. The cell culture supernatant was subjected to plaque purification for the identification of a vaccine candidate without mutations. Of 10 plaque-purified clones, 1 containing no mutation (clone J) was selected for production of the vaccine virus. During subsequent cell culture passaging of this clone for vaccine production, a single amino acid substitution (K to R) occurred in the envelope (E) protein at residue 204 (E204) (F. Guirakhoo, K. Pugachev, Z. Zhang, G. Myers, I. Levenbook, K. Draper, J. Lang, S. Ocran, F. Mitchell, M. Parsons, N. Brown, S. Brandler, C. Fournier, B. Barrere, F. Rizvi, A. Travassos, R. Nichols, D. Trent, and T. Monath, J. Virol.\n            <jats:bold>78:<\/jats:bold>\n            4761-4775, 2004). The same mutation was observed in another clone (clone E). This mutation attenuated the virus in 4-day-old suckling mice inoculated by the intracerebral (i.c.) route and led to reduced viremia in monkeys inoculated by the subcutaneous or i.c. route. The histopathology scores of lesions in the brain tissue of monkeys inoculated with either the E204K or E204R virus were reduced compared to those for monkeys inoculated with the reference virus, a commercial yellow fever 17D vaccine (YF-VAX). Both viruses grew to significantly lower titers than YF-VAX in HepG2, a human hepatoma cell line. After intrathoracic inoculation into mosquitoes, both viruses grew to a similar level as YF-VAX, which was significantly lower than that of their wild-type DEN1 parent virus. A comparison of the E-protein structures of nonmutant and mutant viruses suggested the appearance of new intramolecular bonds between residues 204R, 261H, and 257E in the mutant virus. These changes may be responsible for virus attenuation through a change in the pH threshold for virus envelope fusion with the host cell membrane.\n          <\/jats:p>","DOI":"10.1128\/jvi.78.18.9998-10008.2004","type":"journal-article","created":{"date-parts":[[2004,8,26]],"date-time":"2004-08-26T22:23:27Z","timestamp":1093559007000},"page":"9998-10008","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":43,"title":["A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia\/Viscerotropism for Monkeys"],"prefix":"10.1128","volume":"78","author":[{"given":"F.","family":"Guirakhoo","sequence":"first","affiliation":[{"name":"Acambis, Inc., Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Acambis, Inc., Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Myers","sequence":"additional","affiliation":[{"name":"Acambis, Inc., Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. W.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pugachev","sequence":"additional","affiliation":[{"name":"Acambis, Inc., Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nichols","sequence":"additional","affiliation":[{"name":"Acambis, Inc., Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Brown","sequence":"additional","affiliation":[{"name":"Acambis, Inc., Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Levenbook","sequence":"additional","affiliation":[{"name":"99 Riverchase Court, Rensselaer, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Draper","sequence":"additional","affiliation":[{"name":"Sierra Division, Discovery and Development Services, Charles River Laboratories, Inc., Sparks, Nevada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cyrek","sequence":"additional","affiliation":[{"name":"Sierra Division, Discovery and Development Services, Charles River Laboratories, Inc., Sparks, Nevada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lang","sequence":"additional","affiliation":[{"name":"Aventis Pasteur, Campus Merieux, Marcy-L'Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fournier","sequence":"additional","affiliation":[{"name":"Aventis Pasteur, Campus Merieux, Marcy-L'Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Barrere","sequence":"additional","affiliation":[{"name":"Aventis Pasteur, Campus Merieux, Marcy-L'Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Delagrave","sequence":"additional","affiliation":[{"name":"BioTech Studio LLC, Newark, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. P.","family":"Monath","sequence":"additional","affiliation":[{"name":"Acambis, Inc., Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2000.62.480"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1528"},{"key":"e_1_3_2_4_2","first-page":"1049","year":"2001","unstructured":"Burke, S., and T. P. Monath. 2001. Flaviviruses, p. 1049-1125. In D. M. Knipe et al. (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.","journal-title":"Fields virology"},{"key":"e_1_3_2_5_2","first-page":"989","volume":"51","year":"2002","unstructured":"Centers for Disease Control and Prevention. 2002. Adverse events associated with 17D-derived yellow fever vaccination\u2014United States, 2001-2002. Morb. Mortal. Wkly. Rep.51:989-993.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.65.405"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2003.69.48"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1168"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.16.7290-7304.2001"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1462"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.9.4761-4775.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.12.5477-5485.2000"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9695"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.239.4839.476"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2004.70.89"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2915.2003.00438.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.67.260"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2003.69.17"},{"key":"e_1_3_2_19_2","first-page":"179","volume":"19","year":"2001","unstructured":"Kanesa-Thasan, N., W. Sun, G. Kim-Ahn, S. Van Albert, J. R. Putnak, A. King, B. Raengsakulsrach, H. Christ-Schmidt, K. Gilson, J. M. Zahradnik, D. W. Vaughn, B. L. Innis, J.-F. Saluzzo, and C. H. Hoke. 2001. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine19:179-188.","journal-title":"Vaccine"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1989.40.444"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8570"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(87)80003-3"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.6.5201-5206.1999"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0706.010605"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05327-2"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0832193100"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(03)60009-6"},{"key":"e_1_3_2_28_2","first-page":"1095","unstructured":"Monath, T. P. 2004. Yellow fever vaccine, p. 1095-1176. In S. Plotkin and W. Orenstein (ed.), Vaccine, 4th ed. Saunders, Philadelphia, Pa.","journal-title":"Vaccine"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.4.1742-1751.2000"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.4.1932-1943.2002"},{"key":"e_1_3_2_31_2","unstructured":"National Institutes of Health. 1998. Guide for the care and use of laboratory animals revised ed. Department of Health and Human Services publication no. (NIH) 85-23. National Institutes of Health Bethesda Md."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.2.1032-1038.2004"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)12483-7"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.264"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(03)61011-0"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690024"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05326-0"},{"key":"e_1_3_2_38_2","first-page":"1:208","volume":"77","year":"1988","unstructured":"World Health Organization. 1988. Annex 9. Requirements for yellow fever vaccine. Addendum 1987. W.H.O. Tech. Rep. Ser. no.771:208. World Health Organization, Geneva, Switzerland.","journal-title":"W.H.O. Tech. Rep. Ser. no."},{"key":"e_1_3_2_39_2","unstructured":"World Health Organization. 1998. Requirements for yellow fever vaccine (requirements for biological substances no. 3.) W.H.O. Expert Committee on Biological Standardization 46th report. W.H.O. Tech. Rep. Ser. 872. W.H.O. fact sheet no. 117 revised April 2002. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_40_2","unstructured":"World Health Organization. 2002. W.H.O. fact sheet no. 117. World Health Organization Geneva Switzerland."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.78.18.9998-10008.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.78.18.9998-10008.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:43:55Z","timestamp":1646469835000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.78.18.9998-10008.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,15]]},"references-count":39,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2004,9,15]]}},"alternative-id":["10.1128\/JVI.78.18.9998-10008.2004"],"URL":"https:\/\/doi.org\/10.1128\/jvi.78.18.9998-10008.2004","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,15]]},"assertion":[{"value":"2004-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-09-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}